Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymidylate synthase is a key enzyme in nucleotide biosynthesis, catalyzing the methylation of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), providing the only de novo source of thymidylate for DNA synthesis in human cells[2][4][5]. The "5-FdUMP-Thymidylate Synthase complex" refers to the stable, covalent ternary complex formed when 5-FdUMP (an active metabolite of 5-FU and FUdR) binds irreversibly to the active site of thymidylate synthase in conjunction with the folate cofactor, resulting in potent and persistent enzyme inhibition, thereby blocking DNA synthesis and inducing cell death in rapidly dividing tumor cells[1][3][4][7].
Suicide inhibition of thymidylate synthase, leading to irreversible inhibition of dTMP (deoxythymidine monophosphate) synthesis, causing "thymineless death" of proliferating cells. Incorporation of fluorinated nucleotide analogs into DNA (when inhibition is incomplete or alternative metabolic pathways are engaged).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-FdUMP-Thymidylate Synthase complex.